-

Global $12.18 Billion CBD Gummies Market Forecast to 2028 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "CBD Gummies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Category and Distribution Channel" report has been added to ResearchAndMarkets.com's offering.

The CBD gummies market was valued at US$ 2,133.48 million in 2021 and is projected to reach US$ 12,182.21 million by 2028. It is expected to grow at a CAGR of 28.3% from 2021 to 2028.

CBD or cannabidiol is an active component in cannabis (marijuana). It is gaining huge traction due to its medicinal and healing effects. According to the World Health Organization (WHO), CBD demonstrates no effects suggestive of any misuse or dependency potential in people.

Based on distribution channel, the CBD gummies market is segmented into specialty stores, online retail, and others. The specialty stores segment accounted for the largest market share in 2020. The online retail segment is projected to grow at the fastest CAGR over the forecast period.

E-commerce platforms have registered significant growth as they provide lucrative services, such as home delivery, discounts, offers, cashback, to the customers. Moreover, customers can choose among a wide range of products by comparing different alternatives available.

A variety of CBD gummies brands are available on e-commerce platforms like Amazon.com. Thus, the high availability of CBD gummies brands at affordable prices is one of the key factors driving the online retail segment.

Based on region, the CBD gummies market is segmented into North America, Europe, and the Rest of the World. In 2020, North America held the largest share of the global CBD gummies market, whereas Europe is projected to register the fastest growth over the forecast period. Europe has a significant concentration of cannabis consumers.

Recently, the European Union has legalized CBD; hence, manufacturers of CBD gummies have a strong growth potential across European nations such as France, Germany, the UK, and Poland. CBD gummies consumption is proliferating rapidly across markets in Europe as manufacturers are focusing on lowering the THC content and using clean-label and organic ingredients.

Moreover, CBD regulations are getting softer as authorities in EU Member States now regard CBD as a novel product for food, beverages, and food supplements. These factors are projected to support the growth of the CBD gummies market across Europe over the coming years.

The leading players in the CBD gummies market include Aurora Cannabis, Inc.; Canopy Growth USA, LLC; CBD American Shaman; CV Sciences, Inc.; Diamond CBD; CBDfx; Sunday Scaries; Medix CBD; Reliva CBD; and Fab CBD.

Reasons to Buy

  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global CBD gummies market, thereby allowing players to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth the market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation, and industry verticals.

Key Market Dynamics

Market Drivers

  • Growing Awareness Regarding Health Benefits of CBD
  • Rising Adoption Among Athletes and Sportspersons

Market Restraints

  • Stringent Regulations Regarding Production and Consumption of CBD

Market Opportunities

  • Product Innovations

Future Trends

  • Surging Influence of Social Media and Celebrities

Company Profiles

  • Dixie Brands
  • Aurora Cannabis Inc.
  • Canopy Growth Corporation
  • Sunday Scaries
  • Diamond CBD
  • CBD American Shaman
  • CV Sciences, Inc
  • Medix CBD
  • CBDFx
  • Elixinol

For more information about this report visit https://www.researchandmarkets.com/r/y34yta

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Blockchain and Non-Fungible Tokens new Technologies and the Relevant Law Training Course: Core Principles, Smart Contracts, NFTs, and Decentralized Finance Explained (Online Event: May 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blockchain and Non-Fungible Tokens: Understanding new Technologies and the Relevant Law Training Course (May 20, 2026)" training has been added to ResearchAndMarkets.com's offering. Blockchain is a new technology that could potentially have major impacts in a wide range of industries. It has the potential to dramatically change how business is conducted - but there is no one central authority controlling blockchain, everyone has access to the same information. Are...

Writing Clinical Research with Integrity Training Course: Principles of Medical and Scientific Writing, Including Ethical Standards, Data Integrity, and Plagiarism Prevention (Online: Apr 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers key principles of medical and scientific writing, including ethical standards, data integrity, and plagiarism prevention. Participants will learn how to tailor content for various audiences, structure documents (e.g., manuscripts, protocols), and adhere to writing standards such as clarity, consistency, and correc...

In-Vitro Diagnostic Regulation (EU) 2017/746 Introduction Training Course (Online Event: Apr 16th - Apr 17th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (Apr 16th - Apr 17th, 2026)" training has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition period of five years, is intended to strengthen the current approval system for in-vitro diagnostics and makes substantial changes to the existing IVD Directive (98/79/EC) legislation. The Regulation in...
Back to Newsroom